Healthcare - Biotechnology - NASDAQ - US
$ 1.04
0.971 %
$ 57.2 M
Market Cap
-0.59
P/E
BALANCE SHEET
278 M
ASSETS
40.6 M
LIABILITIES
237 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Prelude Therapeutics Incorporated
| Current Assets | 236 M |
| Cash & Short-Term Investments | 233 M |
| Receivables | 0 |
| Other Current Assets | 2.65 M |
| Non-Current Assets | 42.1 M |
| Long-Term Investments | 0 |
| PP&E | 37.7 M |
| Other Non-Current Assets | 4.34 M |
| Current Liabilities | 21.8 M |
| Accounts Payable | 4.58 M |
| Short-Term Debt | 2.96 M |
| Other Current Liabilities | 14.3 M |
| Non-Current Liabilities | 18.7 M |
| Long-Term Debt | 15.4 M |
| Other Non-Current Liabilities | 3.34 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 25.3 | 30.6 | 31.8 | 218.3 | 18.9 | 15.6 |
| Short Term Investments | 207.6 | 171.1 | 259.4 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 2.7 | 2.7 | 7.8 | 5.0 | 1.3 | 0 |
| Total Current Assets | 235.6 | 204.4 | 295.1 | 220.8 | 20.2 | 15.6 |
| PP&E | 37.7 | 6.7 | 5.6 | 2.5 | 1.6 | 0.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 4.0 | 4.0 | 0 | 0 | 0 |
| Other Long Term Assets | 4.3 | 5.4 | 0.3 | 0.3 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 277.7 | 220.5 | 305.1 | 223.6 | 21.9 | 16.4 |
| LIABILITIES | ||||||
| Accounts Payable | 4.6 | 6.8 | 7.8 | 3.9 | 2.0 | 1.4 |
| Short Term Debt | 3.0 | 3.7 | 3.5 | 0 | 0.3 | 0 |
| Other Current Liabilities | 14.3 | 11.3 | 7.9 | 7.5 | 2.6 | 1.1 |
| Total Current Liabilities | 21.8 | 21.7 | 19.2 | 11.4 | 4.8 | 2.4 |
| Long Term Debt | 15.4 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 3.3 | 3.4 | 0 | 32 K | 66.4 | 36.7 |
| Total Liabilities | 40.6 | 25.1 | 19.2 | 11.4 | 71.3 | 39.1 |
| EQUITY | ||||||
| Common Stock | 5 K | 5 K | 5 K | 4 K | 0 | 0 |
| Retained Earnings | (456.4) | (334.6) | (219.1) | (107.4) | (50.5) | (22.9) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (1.7) | (0.7) | (223.6) | 0 | (0.2) |
| Total Equity | 237.1 | 195.4 | 285.9 | 212.2 | (49.4) | (22.7) |
| Total Liabilities and Equity | 277.7 | 220.5 | 305.1 | 223.6 | 21.9 | 16.4 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 60.4 | 47.4 | 47.6 | 43.7 | 32.4 | 32.1 |